586 related articles for article (PubMed ID: 12383574)
1. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
[TBL] [Abstract][Full Text] [Related]
2. Myocardial perfusion and oxygenation are impaired during stress in severe aortic stenosis and correlate with impaired energetics and subclinical left ventricular dysfunction.
Mahmod M; Francis JM; Pal N; Lewis A; Dass S; De Silva R; Petrou M; Sayeed R; Westaby S; Robson MD; Ashrafian H; Neubauer S; Karamitsos TD
J Cardiovasc Magn Reson; 2014 Apr; 16(1):29. PubMed ID: 24779370
[TBL] [Abstract][Full Text] [Related]
3. Absolute quantification of high energy phosphate metabolites in normal, hypertrophied and failing human myocardium.
Neubauer S; Beer M; Landschütz W; Sandstede J; Seyfarth T; Lipke C; Köstler H; Pabst TKenn W; Meininger M; von Kienlin M; Horn M; Harre K; Hahn D
MAGMA; 2000 Nov; 11(1-2):73-4. PubMed ID: 11186995
[No Abstract] [Full Text] [Related]
4. Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy.
Beer M; Wagner D; Myers J; Sandstede J; Köstler H; Hahn D; Neubauer S; Dubach P
J Am Coll Cardiol; 2008 May; 51(19):1883-91. PubMed ID: 18466804
[TBL] [Abstract][Full Text] [Related]
5. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
Neubauer S; Horn M; Pabst T; Harre K; Strömer H; Bertsch G; Sandstede J; Ertl G; Hahn D; Kochsiek K
J Investig Med; 1997 Oct; 45(8):453-62. PubMed ID: 9394098
[TBL] [Abstract][Full Text] [Related]
6. [The quantification of energy-rich phosphates in healthy and damaged heart muscle by SLOOP 31P-MR spectroscopy. Spatial localization with optimal pointspread function].
Beer M; Landschütz W; Meininger M; Seyfarth T; Viehrig M; Sandstede J; Pabst T; Kenn W; Horn M; Harre K; von Kienlin M; Neubauer S; Hahn D
Rofo; 1999 Jul; 171(1):65-8. PubMed ID: 10464508
[TBL] [Abstract][Full Text] [Related]
7. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.
Hardy CJ; Weiss RG; Bottomley PA; Gerstenblith G
Am Heart J; 1991 Sep; 122(3 Pt 1):795-801. PubMed ID: 1877457
[TBL] [Abstract][Full Text] [Related]
8. Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy.
Pluim BM; Lamb HJ; Kayser HW; Leujes F; Beyerbacht HP; Zwinderman AH; van der Laarse A; Vliegen HW; de Roos A; van der Wall EE
Circulation; 1998 Feb; 97(7):666-72. PubMed ID: 9495302
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy.
Meininger M; Landschütz W; Beer M; Seyfarth T; Horn M; Pabst T; Haase A; Hahn D; Neubauer S; von Kienlin M
Magn Reson Med; 1999 Apr; 41(4):657-63. PubMed ID: 10332840
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging.
Hansch A; Rzanny R; Heyne JP; Leder U; Reichenbach JR; Kaiser WA
Eur Radiol; 2005 Feb; 15(2):319-23. PubMed ID: 15630572
[TBL] [Abstract][Full Text] [Related]
11. Functional and metabolic evaluation of the hypertrophied heart using MRI and 31P-MRS.
Lamb HJ; van der Laarse A; Pluim BM; Beyerbacht HP; Doornbos J; van der Wall EE; de Roos A
MAGMA; 1998 Sep; 6(2-3):168-70. PubMed ID: 9803400
[No Abstract] [Full Text] [Related]
12. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
Neubauer S; Horn M; Cramer M; Harre K; Newell JB; Peters W; Pabst T; Ertl G; Hahn D; Ingwall JS; Kochsiek K
Circulation; 1997 Oct; 96(7):2190-6. PubMed ID: 9337189
[TBL] [Abstract][Full Text] [Related]
13. In vivo mouse myocardial (31)P MRS using three-dimensional image-selected in vivo spectroscopy (3D ISIS): technical considerations and biochemical validations.
Bakermans AJ; Abdurrachim D; van Nierop BJ; Koeman A; van der Kroon I; Baartscheer A; Schumacher CA; Strijkers GJ; Houten SM; Zuurbier CJ; Nicolay K; Prompers JJ
NMR Biomed; 2015 Oct; 28(10):1218-27. PubMed ID: 26269430
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of rapid-sequence 31P magnetic resonance spectroscopy in cardiac patients.
Chida K; Otani H; Saito H; Nagasaka T; Kagaya Y; Kohzuki M; Zuguchi M; Shirato K
Acta Radiol; 2005 Jul; 46(4):386-90. PubMed ID: 16134315
[TBL] [Abstract][Full Text] [Related]
15. Mitral regurgitation: impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans.
Conway MA; Bottomley PA; Ouwerkerk R; Radda GK; Rajagopalan B
Circulation; 1998 May; 97(17):1716-23. PubMed ID: 9591766
[TBL] [Abstract][Full Text] [Related]
16. Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study.
Beer M; Sandstede J; Weilbach F; Spindler M; Buchner S; Krug A; Köstler H; Pabst T; Kenn W; Landschütz W; von Kienlin M; Toyka KV; Ertl G; Gold R; Hahn D
Rofo; 2001 May; 173(5):399-404. PubMed ID: 11414146
[TBL] [Abstract][Full Text] [Related]
17. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
Neubauer S; Krahe T; Schindler R; Horn M; Hillenbrand H; Entzeroth C; Mader H; Kromer EP; Riegger GA; Lackner K
Circulation; 1992 Dec; 86(6):1810-8. PubMed ID: 1451253
[TBL] [Abstract][Full Text] [Related]
18. [31P Magnetic Resonance Spectroscopy in Patients With Various Genesis of Left Ventricular Hypertrophy].
Ternovoy SK; Mazaev VV; Stukalova OV; Serova NS
Kardiologiia; 2015; 55(9):5-9. PubMed ID: 26898088
[TBL] [Abstract][Full Text] [Related]
19. Age and gender dependence of human cardiac phosphorus metabolites determined by SLOOP 31P MR spectroscopy.
Köstler H; Landschütz W; Koeppe S; Seyfarth T; Lipke C; Sandstede J; Spindler M; von Kienlin M; Hahn D; Beer M
Magn Reson Med; 2006 Oct; 56(4):907-11. PubMed ID: 16964598
[TBL] [Abstract][Full Text] [Related]
20. Altered relative concentrations of high-energy phosphates in patients with uraemic cardiomyopathy measured by magnetic resonance spectroscopy.
Patel RK; Mark PB; Macnaught G; Stevens KK; McQuarrie EP; Steedman T; Gillis K; Dargie HJ; Jardine AG
Nephrol Dial Transplant; 2012 Jun; 27(6):2446-51. PubMed ID: 22241795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
